Financial statements Flc Pharma
Balance sheet data of FLC PHARMA
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Total assets | 2 358 188,51 | 617 053,33 | 615 721,31 |
| A. Fixed assets | 195 865,71 | 142 051,18 | 101 615,34 |
| B. Current assets | 2 162 322,80 | 475 002,15 | 514 105,97 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 358 188,51 | 617 053,33 | 615 721,31 |
| A. Equity | -4 222 441,27 | -5 056 584,12 | -5 167 072,71 |
| B. Liabilities and provisions for liabilities | 6 580 629,78 | 5 673 637,45 | 5 782 794,02 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 6 580 629,78 | 5 673 637,45 | 5 782 794,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.